William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Eagle Pharmaceuticals (EGRX) Vasopressin Patent Win Removes Overhang - William Blair
-
Eagle Pharmaceuticals to Present at June Investor Conferences
-
Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June
-
Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June
-
Eagle Pharmaceuticals to Present at Upcoming June Conferences
-
Notable Analyst Rating Changes 6/22: (MET) (PGR) (SNDK) Upgraded; (ALL) (SYMC) (PLCM) Downgraded
-
Eagle Pharmaceuticals to Present at Two Investor Conferences in June
-
Eagle Pharmaceuticals (EGRX) 1.3M Offering Priced at $42/Share
-
Eagle Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Eagle Pharmaceuticals (EGRX) Commences $50M Stock Offering
-
Eagle Pharmaceuticals Announces Commencement of Public Offering of Common Stock
-
William Blair Starts Eagle Pharmaceuticals (EGRX) at Outperform
-
Eagle Pharmaceuticals (EGRX) IPO Opens Higher

